Stock Market Reviews

MRNA (Moderna, Inc.) News

Get the latest news, insights, and market updates on MRNA (Moderna, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Moderna (MRNA) Is Up 5.9% After EMA Backs New mNEXSPIKE Vaccine - Has The Bull Case Changed?
  The European Medicines Agency’s Committee for Medicinal Products for Human Use previously issued a positive opinion recommending marketing authorization of Moderna’s new COVID-19 vaccine, mNEXSPIKE (mRNA-1283), for individuals aged 12 and older, following Phase 3 data showing higher relative efficacy versus Spikevax. This potential EU approval would broaden Moderna’s respiratory vaccine lineup and regional footprint, partly counterbalancing pressure from weakening COVID-19 vaccine...
  Dec 16, 2025 - $MRNA
• CHMP Backs EU Approval of MRNA's New COVID-19 Vaccine mNexspike
  CHMP backs EU approval of Moderna's next-generation mNexspike COVID-19 vaccine, with a final European Commission decision expected shortly.
  Dec 16, 2025 - $MRNA
• ‘Zombie’ biotech buyer Xoma to acquire Generation Bio
  The gene therapy developer has lost most of its value since going public in 2020 and saw a long road ahead for a delivery technology that had shown promise in preclinical tests.
  Dec 16, 2025 - $MRNA
• 3 Cash-Burning Stocks We Steer Clear Of
  Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.
  Dec 15, 2025 - $MRNA
• EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)
  mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine) mNEXSPIKE will be available in the European Union, subject to authorization by the ...
  Dec 15, 2025 - $MRNA
• Amazon and 9 More Stocks to Buy for 2026
  Barron’s capitalized on the trends with Alibaba Group Holding Alphabet and ASML Holding as well as other winners, including Citigroup and Uber Technologies in our top 10 picks for 2025. Rounding out the list is pharmaceutical turnaround candidate Bristol Myers Squibb which yields almost 5%.
  Dec 15, 2025 - $MRNA
• Roblox downgraded, Lululemon upgraded: Wall Street's top analyst calls
  Roblox downgraded, Lululemon upgraded: Wall Street's top analyst calls
  Dec 12, 2025 - $MRNA
• Moderna Secures $1.5B Five-Year Loan from Ares Management Ahead of Strategy Update
  Moderna Inc. (NASDAQ:MRNA) is one of the high short interest stocks to buy right now. On November 20, Moderna announced that it had secured a five-year loan of $1.5 billion from Ares Management Corp (NYSE:ARES). The company made this announcement as it prepared to unveil strategy updates to analysts later that day. Moderna plans to […]
  Dec 11, 2025 - $MRNA
• Moderna Sounds the Alarm: Is China About to Seize the Biotech Crown from the U.S.?
  Noubar Afeyan says American hesitation is creating a strategic opening China is moving fast to exploit.
  Dec 11, 2025 - $MRNA
• Moderna signs deal worth up to $503m with Nanexa
  Moderna is seeking to enhance some of its drugs with Nanexa’s technology as the biologics sector moves to less frequent dosing.
  Dec 11, 2025 - $MRNA